Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Harmful Algae|November 29, 2024
Molecular investigation of harmful cyanobacteria reveals hidden risks and niche partitioning in Kenyan LakesBrittany N Zepernick, Lauren N Hart, Emily E Chase, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancerHernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
British Journal of Haematology|September 24, 2023
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemiasCatherine Mark, Soheil Meshinchi, Brooklyn Joyce, et al.
Blood|May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology GroupKatherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Blood|September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid LeukemiaEmilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Haematologica|January 13, 2022
Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children's Oncology Group studyFieke W Hoff, Anneke D Van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid LeukemiaJason E Farrar, Jenny L Smith, Megan Othus, et al.
Microbiology Resource Announcements|October 4, 2024
Diel metatranscriptomes capture cyanobacteria-dominated Lake Erie community response to episodic eventsBrittany N Zepernick, Anna G Boegehold, E Anders Kiledal, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Harmful Algae|November 29, 2024
Molecular investigation of harmful cyanobacteria reveals hidden risks and niche partitioning in Kenyan LakesBrittany N Zepernick, Lauren N Hart, Emily E Chase, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancerHernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
British Journal of Haematology|September 24, 2023
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemiasCatherine Mark, Soheil Meshinchi, Brooklyn Joyce, et al.
Blood|May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology GroupKatherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Blood|September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid LeukemiaEmilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Haematologica|January 13, 2022
Clinical relevance of proteomic profiling in <i>de novo</i> pediatric acute myeloid leukemia: a Children's Oncology Group studyFieke W Hoff, Anneke D Van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid LeukemiaJason E Farrar, Jenny L Smith, Megan Othus, et al.
Microbiology Resource Announcements|October 4, 2024
Diel metatranscriptomes capture cyanobacteria-dominated Lake Erie community response to episodic eventsBrittany N Zepernick, Anna G Boegehold, E Anders Kiledal, et al.
Pageof 25